Analyst Downgrade: Recent commentary on social media has focused on a shift in analyst views for Astera Labs, with one firm moving its rating to Market Perform. Observers note that this adjustment comes amid broader market volatility in the semiconductor sector. The change has prompted questions about near-term momentum despite ongoing operational progress.
Insider Activity: Discussions also highlight reports of significant insider share sales even as the stock has continued to climb. Participants express surprise at the divergence between these transactions and price action, with some viewing it as a potential signal for caution. Others suggest automated trading dynamics may be overriding traditional signals in the current environment.
Long-Term Outlook: A number of voices emphasize the company's positioning in data center connectivity, citing ambitions for substantial market expansion over time. These comments point to potential for meaningful growth if key technological goals are met. Overall, the tone reflects cautious optimism tempered by short-term uncertainties.
Note: This discussion summary was generated from an AI condensation of post data.
Astera Labs Insider Trading Activity
Astera Labs insiders have traded $ALAB stock on the open market 210 times in the past 6 months. Of those trades, 0 have been purchases and 210 have been sales.
Here’s a breakdown of recent trading of $ALAB stock by insiders over the last 6 months:
- SANJAY GAJENDRA (President and COO) has made 0 purchases and 33 sales selling 870,415 shares for an estimated $219,129,075.
- JITENDRA MOHAN (Chief Executive Officer) has made 0 purchases and 68 sales selling 950,464 shares for an estimated $162,147,146.
- MANUEL ALBA has made 0 purchases and 45 sales selling 366,000 shares for an estimated $50,104,598.
- PHILIP MAZZARA (General Counsel and Secretary) has made 0 purchases and 46 sales selling 49,721 shares for an estimated $8,130,997.
- STEFAN A DYCKERHOFF has made 0 purchases and 6 sales selling 24,998 shares for an estimated $4,376,257.
- MICHAEL TRUETT TATE (Chief Financial Officer) has made 0 purchases and 5 sales selling 12,001 shares for an estimated $1,485,784.
- JACK R LAZAR has made 0 purchases and 7 sales selling 10,000 shares for an estimated $1,223,471.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
Astera Labs Revenue
Astera Labs had revenues of $308.4M in Q1 2026. This is an increase of 93.4% from the same period in the prior year.
You can track ALAB financials on Quiver Quantitative's ALAB stock page.
You can access data on ALAB stock through the Quiver Quantitative API.
Astera Labs Hedge Fund Activity
We have seen 390 institutional investors add shares of Astera Labs stock to their portfolio, and 426 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VAN ECK ASSOCIATES CORP added 1,819,597 shares (+4059.9%) to their portfolio in Q1 2026, for an estimated $190,812,039
- ATREIDES MANAGEMENT, LP added 1,754,593 shares (+108.9%) to their portfolio in Q1 2026, for an estimated $183,995,394
- BLACKROCK, INC. removed 1,519,089 shares (-11.7%) from their portfolio in Q1 2026, for an estimated $159,299,267
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 1,507,675 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $250,816,813
- BNP PARIBAS FINANCIAL MARKETS added 1,016,432 shares (+127.5%) to their portfolio in Q1 2026, for an estimated $106,588,141
- AMUNDI added 823,477 shares (+77.9%) to their portfolio in Q1 2026, for an estimated $86,353,915
- LORD, ABBETT & CO. LLC removed 767,744 shares (-81.4%) from their portfolio in Q1 2026, for an estimated $80,509,474
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Astera Labs Analyst Ratings
Wall Street analysts have issued reports on $ALAB in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 05/06/2026
- Loop Capital issued a "Buy" rating on 03/05/2026
- RBC Capital issued a "Outperform" rating on 01/15/2026
To track analyst ratings and price targets for Astera Labs, check out Quiver Quantitative's $ALAB forecast page.
Astera Labs Price Targets
Multiple analysts have issued price targets for $ALAB recently. We have seen 15 analysts offer price targets for $ALAB in the last 6 months, with a median target of $245.0.
Here are some recent targets:
- Mark Lipacis from Evercore ISI Group set a target price of $297.0 on 05/19/2026
- Tom O'Malley from Barclays set a target price of $200.0 on 05/07/2026
- Joseph Moore from Morgan Stanley set a target price of $240.0 on 05/06/2026
- Harlan Sur from JP Morgan set a target price of $280.0 on 05/06/2026
- Sean O'Loughlin from TD Cowen set a target price of $225.0 on 05/06/2026
- Papa Sylla from Citigroup set a target price of $245.0 on 05/06/2026
- Srini Pajjuri from RBC Capital set a target price of $270.0 on 05/06/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
